Starry Pharmaceutical

Zhejiang Starry Pharmaceutical Co., Ltd., established in 1997, is a national high-tech enterprise based in China. The company specializes in the research and development, manufacture, and marketing of active pharmaceutical ingredients and intermediates. Its product portfolio includes a series of X-CT non-ionic contrast agents and Fluoroquinolones. Starry Pharmaceutical is committed to advancing medical imaging and antibiotic solutions through innovative technologies and high-quality manufacturing processes.

Weiyi Shen

General Manager and Vice Chairman

1 past transactions

Yannuo Pharmaceutical

Series A in 2023
Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conducts research and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.